Microalbuminuria in nondiabetic adults: Relation of blood pressure, body mass index, plasma cholesterol levels, and smoking: The Gubbio Population Study

Archives of Internal Medicine

Volumn 158, Issue 17, 1998, Pages 1933-1939

  Cirillo, Massimo ^a,b   Senigalliesi, Luigi ^a   Laurenzi, Martino ^b,c   Alfieri, Raffaele ^d   Stamler, Jeremiah ^b   Stamler, Rose ^b   Panarelli, Walter ^e   De Santo, Natale G ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b NORTHWESTERN UNIVERSITY   (United States)

^c Regional Epidemiological Centre   (Italy)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^e Civil Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALCOHOL; CHOLESTEROL; CREATININE; GLUCOSE; LITHIUM ION; SODIUM ION; TRIACYLGLYCEROL; URIC ACID;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR DISEASE; CATION TRANSPORT; CONTROLLED STUDY; FEMALE; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SMOKING;

ALBUMINURIA; ANALYSIS OF VARIANCE; BODY MASS INDEX; CHOLESTEROL; CREATININE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERTENSION; ITALY; LINEAR MODELS; LOGISTIC MODELS; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; SMOKING;

EID: 0032575930     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.158.17.1933     Document Type: Article

References (47)

1. Viberti GC, Wiseman MJ. The kidney in diabetes: significance of the early abnormalities. Clin Endocrinol Metab. 1986;15:753-782.
2. Bennet PH, Haffner S, Kasiske BL, et al. Screening and management of microalbuminuria in patients with diabetes mellitus: recommendations to the Scientific Advisory Board of the National Kidney Foundation from an ad hoc Committee of the Council on Diabetes Mellitus of the National Kidney Foundation. Am J Kidney Dis. 1995;25:107-112.
3. Ravid M, Savin HS, Lang R, Jutrin I, Shoshanna L, Lishner M. Proteinuria, renal impairment, metabolic control, and blood pressure in type 2 diabetes mellitus. Arch Intern Med. 1992;152:1225-1229.
4. Savage S, Nagel NJ, Estacio RO, Lukken N, Schrier RW. Clinical factors associated with urinary albumin excretion in type II diabetes. Am J Kidney Dis. 1995; 25:836-844.
5. Viberti GC, Jarret RJ, Mahmud U, Hill RD, Argyropoulos A, Keen H. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet. 1982;1:1430-1432.
6. Parving HH, Oxenboll B, Svendsen PA, Christiansen SJ, Andersen AR. Early detection of patients at risk of developing diabetic nephropathy: a longitudinal study of urinary albumin excretion. Acta Endocrinol. 1982;100:550-555.
7. Mogensen CE, Christensen CK. Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med. 1984;311:89-93.
8. Mathiensen ER, Oxenboll B, Johansen K, Svendsen PA, Deckert T. Incipient nephropathy in type 1 (insulin-dependent) diabetes. Diabetologia. 1984;26:406-410.
9. Messent JWC, Elliott TG, Hill RD, Jarret RJ, Keen H, Viberti GC. Prognostic significance of microalbuminuria in insulin-dependent diabetes mellitus: a twenty-three year follow-up study. Kidney Int. 1992;41:836-839.
10. Klag MJ, Whelton PK, Randall BL, et al. Blood pressure and end-stage renal disease in men. N Engl J Med. 1996;334:13-18.
11. Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Stamler J. End-stage renal disease in African-American and white men. JAMA. 1997;277:1293-1298.
12. Klag MJ, Whelton PK, Randall B, et al. Serum cholesterol and end-stage renal disease in men screened for the MRFIT [abstract]. J Am Soc Nephrol. 1995;6: 393. Abstract 84.
13. Whelton PK, Randall B, Neaton JD, Stamler J, Brancati FL, Klag MJ. Cigarette smoking and end-stage renal disease in men screened for the MRFIT [abstract]. J Am Soc Nephrol. 1995;6:408. Abstract 88.
14. Orth SR, Stockmann A, Conradt C, Ritz E. Smoking increases the risk to progress to end-stage renal failure in men with primary renal disease. Nephrology. 1997; 3(suppl):S505. Abstract P1734.
15. Gosling P, Beevers DG. Urinary albumin excretion and blood pressure in the general population. Clin Sci. 1989;76:39-42.
16. Vestbo E, Damsgaard EM, Froland A, Mogensen CE. Microalbuminuria in a population-based cohort: ways of expression of albuminuria (Fredericia Study Second Generation). J Diabetes Complications. 1994;8:176-177.
17. Jiang X, Srinivasan SR, Radhakrishnamurthy B, Dalferes ER, Bao W, Berenson GS. Microalbuminuria in young adults related to blood pressure in a biracial (black-white) population: The Bogalusa Heart Study. Am J Hypertens. 1994;7:794-800.
18. Tichet J, Vol S, Hallab M, Caces E, Marre M. Epidemiology of microalbuminuria in a French population. J Diabetes Complications. 1994;8:174-175.
19. Metcalf PA, Baker J, Scott AJ, Wild CJ, Scragg R, Dryson E. Albuminuria in people at least 40 years old: effect of obesity, hypertension, and hyperlipidemia. Clin Chem. 1992;38:1802-1808.
20. Metcalf PA, Baker J, Scragg R, Dryson E, Scott AJ, Wild CJ. Albuminuria in people at least 40 years old: effect of alcohol consumption, regular exercise, and cigarette smoking. Clin Chem. 1993;39:1793-1797.
21. Laurenzi M, Trevisan M. Sodium-lithium countertransport and blood pressure: the Gubbio Population Study. Hypertension. 1989;13:408-415.
22. Trevisan M, Laurenzi M. Correlates of sodium-lithium countertransport: findings from the Gubbio epidemiological study. Circulation. 1991;84:2011-2019.
23. Cirillo M, Trevisan M, Laurenzi M. Calcium binding capacity of erythrocyte membrane in human hypertension. Hypertension. 1989;14:152-155.
24. Laurenzi M, Cirillo M, Angeletti M, et al. Gubbio Population Study: baseline findings. Nutr Metab Cardiovasc Dis. 1991;1(suppl):S1-S18.
25. Cirillo M, Laurenzi M, Trevisan M. Hematocrit, blood pressure, and hypertension: the Gubbio Population Study. Hypertension. 1992;20:319-326.
26. Cirillo M, Laurenzi M, Panarelli W, Stamler J. Urinary sodium to potassium ratio and urinary stone disease. Kidney Int. 1994;46:1133-1139.
27. Cirillo M, Laurenzi M, Trevisan M, Panarelli W, Stamler J. Sodium-lithium countertransport and blood pressure change overtime: the Gubbio Study. Hypertension. 1996;27:1305-1311.
28. Laurenzi M, Cirillo M, Trevisan M, Panarelli W, Stamler J. Baseline sodium-lithium countertransport and 6-year incidence of hypertension: the Gubbio Population Study. Circulation. 1997;95:581-587.
29. Pesce AJ, Hsu A, Kornhauser C, Sethi K, Ooi BS, Pollak VE. Method for measuring the concentration of urinary proteins according to their molecular size category. Clin Chem. 1976;22:667-672.
30. Ruilope LM, Rodicio JL. Microalbuminuria in clinical practice. Kidney Curr Survey World Lit. 1995;4:211-216.
31. Praga M, Hernandez E, Andres A, Leon M, Ruilope LM, Rodicio JL. Effects of body-weight loss and captopril treatment on proteinuria associated with obesity. Nephron. 1995;70:35-41.
32. Bottazzo S, Sever G, Toffoletto P, Fazzin G. Microalbuminuria in primary hypercholesterolemia [abstract in English]. Giorn It Nefrol. 1996;13:19-23.
33. Hutchinson FN. Proteinuria, hyperlipidemia and the kidney. Miner Electrolyte Metab. 1993;19:127-136.
34. Al-Shebeb T, Frohlich J, Magil AB. Glomerular disease in hypercholesterolemic guinea pigs. Kidney Int. 1988;33:498-507.
35. Kasiske BL, O'Donnel MP, Schmitz PG, Kim Y, Keane WF. Renal injury of diet-induced hypercholesterolemia in rats. Kidney Int. 1990;37:880-891.
36. Bank N. Renal hemodynamic consequences of hypertipidemia. Miner Electrolyte Metab. 1993;19:165-172.
37. Guijaro C, Kasiske BL, Kim Y, O'Donnel MP, Lee HS, Keane WF. Early glomerular changes in rats with dietary-induced hypercholesterolemia. Am J Kidney Dis. 1995;26:152-161.
38. Dubois D, Chanson P, Timsit J, et al. Remission of proteinuria following correction of hyperlipidemia in non-insulin-dependent patients with non-diabetic glomerulopathy. Diabetes Care. 1994;17:906-908.
39. Foster DM. Insulin resistance: a secret killer? N Engl J Med. 1989;320:733-734.
40. Jensen JS, Borch-Johnsen K, Jensen G, Rasmussen BF. Atherosclerotic risk factors are increased in clinically healthy subjects with microalbuminuria. Atherosclerosis. 1995;112:245-252.
41. Winocour PH, Harland JOE, Millar JP, Laker MF, Alberti KGMM. Microalbuminuria and associated cardiovascular risk factors in the community. Atherosclerosis. 1992;93:71-81.
42. Cockroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31-41.
43. Damsgaard EM, Froland A, Jorgensen OD, Mogensen CR. Eight to nine year mortality in known non-insulin dependent diabetics and controls. Kidney Int. 1992; 41:731-735.
44. Deckert T, Yokoyama H, Mathiesen E, et al. Cohort study of predictive value of urinary albumin excretion for atherosclerotic vascular disease in patients with insulin dependent diabetes. BMJ. 1996;312:871-874.
45. Yudkin JS, Forrest RV, Jackson CA. Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Lancet. 1988;2:531-534.
46. Damsgaard EM, Froland A, Jorgensen OD, Mogensen CE. Microalbuminuria as predictor of increased mortality in elderly people. BMJ. 1990;300:297-300.
47. Agewall S, Wikstrand J, Ljunghman S, Herlitz H, Fagerberg B. Does microalbuminuria predict cardiovascular events in nondiabetic men with treated hypertension? Am J Hypertens. 1995;8:337-342.